Moreover, the downregulation of ASCL1 mRNA and protein levels by iBAP-II treatment was also validated in other SCLC cell lines NCI-H748 and NCI-H1882 (Supplementary Fig. 3A, B). The gene discussed is ASCL1; the disease is small cell lung carcinoma.